Human embryonic stem cells (hESCs), derived from the inner cell mass (ICM) of the blastocyst, have the capacity for longterm undifferentiated growth in culture and the theoretical potential to differentiate into all somatic cell types. [1] These hESCs offer not only a model system for human developm
Small-Molecule Regulators of Human Stem Cell Self-Renewal
β Scribed by Dr. Laure C. Bouchez; Dr. Anthony E. Boitano; Lorenzo de Lichtervelde; Russell Romeo; Dr. Michael P. Cooke; Prof. Dr. Peter G. Schultz
- Publisher
- John Wiley and Sons
- Year
- 2011
- Tongue
- English
- Weight
- 365 KB
- Volume
- 12
- Category
- Article
- ISSN
- 1439-4227
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Human embryonic stem cells (hESCs), derived from the inner cell mass (ICM) of the blastocyst, have the capacity for longterm undifferentiated growth in culture and the theoretical potential to differentiate into all somatic cell types. [1] These hESCs offer not only a model system for human developm
## Abstract Human embryonic stem cells (hESCs) have the potential to differentiate into all cell types in the body and hold great promise for regenerative medicine; however, largeβscale expansion of undifferentiated hESCs remains a major challenge. Selfβrenewal of hESCs requires culturing these cel
## Abstract Differentiation and selfβrenewal are two primary properties that characterize stem cells. Differentiation of neural stem/precursor cells (NSPCs) gives rise to multiple neural lineages, including neurons, astrocytes, and oligodendrocytes. Selfβrenewal, by definition, signifies the progre
## Abstract Mouse embryonic stem (mES) cells are pluripotent cells that can be propagated in vitro with leukemia inhibitory factor (LIF) and serum. Intracellular signaling by LIF is principally mediated by activation of STATβ3, although additional pathways for selfβrenewal have been described. Here
The team of Liu et al. generated endoderm-derived human induced pluripotent stem (iPS) cells from primary hepatocytes. 1 However, they generated human iPS cells by using viral transgenes. 1 Clinical applications of human iPS cells require avoiding viral transgenes. On the other hand, the reprogrammi